The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
Clinical trial NCT02211209 · COMPLETED
Trial details
- NCT number
- NCT02211209
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-12-19
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.